Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 4 (2007), Issue 8 (August)

1. Stable insertion of Alzheimer Abeta peptide into the ER membrane strongly correlates with its length.
   FEBS Lett, 581(20): 3809-13. [Abstract] [Full-text]
2. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
   Biochem Biophys Res Commun, 361(1): 116-21. [Abstract] [Full-text]
3. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.
   J Biol Chem, 282(32): 23645-54. [Abstract] [Full-text]
4. {gamma}-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: IMPLICATIONS FOR ALZHEIMER DISEASE.
   J Biol Chem, 282(32): 23639-44. [Abstract] [Full-text]
5. Asymptomatic spontaneous cerebral emboli predict cognitive and functional decline in dementia.
   Biol Psychiatry, 62(4): 339-44. [Abstract] [Full-text]
6. Conceptual fluency at test shifts recognition response bias in Alzheimer's disease: implications for increased false recognition.
   Neuropsychologia, 45(12): 2791-801. [Abstract] [Full-text]
7. A meta-analytic review of category naming in Alzheimer's disease.
   Neuropsychologia, 45(12): 2674-82. [Abstract] [Full-text]
8. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.
   J Exp Med, 204(8): 1999-2008. [Abstract] [Full-text]
9. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
   Biochemistry, 46(32): 9270-82. [Abstract] [Full-text]
10. Positioning of the Alzheimer Abeta(1-40) peptide in SDS micelles using NMR and paramagnetic probes.
    J Biomol NMR, 39(1): 63-72. [Abstract] [Full-text]
11. Effects of Alzheimer's disease on different cortical layers: the role of intrinsic differences in Abeta susceptibility.
    J Neurosci, 27(32): 8496-504. [Abstract] [Full-text]
12. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases.
    Macromol Biosci, 7(8): 1065-74. [Abstract] [Full-text]
13. Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review.
    J Neurol Neurosurg Psychiatry, 78(9): 917-28. [Abstract] [Full-text]
14. CSF neurofilament proteins in the differential diagnosis of dementia.
    J Neurol Neurosurg Psychiatry, 78(9): 936-8. [Abstract] [Full-text]
15. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.
    Neurobiol Aging, 28(10): 1484-92. [Abstract] [Full-text]
16. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Neurobiol Aging, 28(10): 1465-80. [Abstract] [Full-text]
17. When conjugated polymers meet amyloid fibrils.
    ACS Chem Biol, 2(8): 525-8. [Abstract] [Full-text]
18. Dementia, delusions and seizures: storage disease or genetic AD?
    Eur J Neurol, 14(9): 1057-9. [Abstract] [Full-text]
19. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Neurology, 69(9): 878-85. [Abstract] [Full-text]
20. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
    Neurology, 69(9): 871-7. [Abstract] [Full-text]
21. Visualization of beta-secretase cleavage in living cells using a genetically encoded surface-displayed FRET probe.
    Biochem Biophys Res Commun, 362(1): 25-30. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.